openPR Logo
Press release

Plasma Protease C1-inhibitor Treatment Market : Segmental Highlights and Table of Content (2017-2025)

12-11-2017 08:15 AM CET | Health & Medicine

Press release from: Transparency Market Research

Plasma Protease C1-inhibitor Treatment Market : Segmental

Global Plasma Protease C1-inhibitor Treatment Market: Players Focus on Expanding Product Portfolio to Expand Outreach, says TMR

A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are some other key vendors that hold significant shares in the overall market for plasma protease C1-inhibitor treatment.

According to estimations of the TMR report, the demand in the global plasma protease c1-inhibitor treatment market will expand at a strong 20.0% CAGR for the forecast period of 2017 to 2025, for the market to be evaluated at US$7.9 bn by 2025-end considerably up from its evaluated worth of US$1.5 bn in 2016. Key vendors in the plasma protease c1-inhibitor treatment market are engaged in expanding their product portfolio and expand their distribution networks in order to penetrate global markets. This has mandated vendors to meet the regulatory standards set by governing bodies at national and international level.

Report overview @ https://www.transparencymarketresearch.com/plasma-protease-c1inhibitor-treatment-market.html

The global Plasma Protease C1-inhibitor Treatment Market is segmented on the basis of Drug Class, Distribution Channel, end user and region.

In terms of drug class, the global plasma protease C1-inhibitor treatment market witness maximum demand from the segment of c1-inhibitors that led amongst other segments in 2016. Geography-wise, the report assesses North America to be the most profitable market for plasma protease c1-inhibitor treatment, which accounted for a demand worth US$1,510.5 mn in 2017.

Growing investment for innovation in inhibitor drugs, promising pipeline drugs and novel therapies, and increasing awareness for hereditary angioedema (HAE) are primarily driving the plasma protease C1-inhibitor market through 2025.

Request to sample report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33116

One of the key drivers of the plasma protease C1-inhibitor treatment market is the increasing usage of plasma protease C1-inhibitor treatment drugs due to the increasing incidence of acute cases of hereditary angioedema (HAE) and prophylaxis. The emergence of C1-inhibitor is considered to be a major breakthrough among several drugs introduced in the plasma protease C1-inhibitor treatment market. Berinert is a C1-esterase inhibitor for acute HAE that received approval from the European Union in 2011. Haegarda, which is derived from C1-esterase inhibitor is approved in the U.S for routine prophylaxis as a preventive measure against HAE attacks in adolescents and adults.

Increasing practice of administering prophylactic treatment process for HAE patient, demand for a new route of administration of C1-inhibitor drugs, rising demand for administering drugs subcutaneously among HAE patients are some other growth drivers of the plasma protease C1-inhibitor treatment market.

Apart from this, commercialization of drugs such as Ruconest in emerging markets of Asia Pacific is likely to boost the C1-inhibitor segment in the upcoming years.

Research studies underway for the development of bradykinin B2 receptor antagonist for the treatment of HAE attacks is likely to propel the global plasma protease C1-inhibitor treatment market. At present, Firazyr is the only approved bradykinin B2 receptor for the treatment of acute HAE attack. FR 173657 is another bradykinin B2 receptor that researchers are evaluating for efficacy for acute HAE attack.

Summary of Table of Content

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary : Global Plasma Protease C1-Inhibitor Treatment Market

4. Market Overview

5. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Drug Class

6. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Dosage Type

7. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Distribution Channel

8. Global Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecasts, By Region

9. North America Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

10. Europe Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

11. Latin America Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

12. Rest of World Plasma Protease C1-Inhibitor Treatment Market Analysis and Forecast

13. Competition Landscape

14. Key Take Aways

Get full report now @ https://www.transparencymarketresearch.com/checkout.php?rep_id=33116<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Protease C1-inhibitor Treatment Market : Segmental Highlights and Table of Content (2017-2025) here

News-ID: 853622 • Views: 1699

More Releases from Transparency Market Research

Aged Care Market set to witness surge in demand over the forecast period
Global Aged Care Market: Snapshot As the percentage of geriatrics in the global population increments, projected to be 17 percent (1.6 billion) by the end of 2050 by the National Institute of Aging, the demand in the global aged care will simultaneously gain momentum. But escalating consumer base is not the only driver for the global aged care market, which will also gain from the advent of robots, who have the
Global Veterinary Ultrasound Scanners Industry Outlook Size, Share, Trend, Growt …
This report provides forecast and analysis of the veterinary ultrasound scanners market on the global and regional levels. It provides historical data of 2015 along with forecast from 2017 to 2025 in terms of revenue (US$ Mn) and volume (units). The report also includes macroeconomic indicators along with an outlook on veterinary ultrasound scanners globally. It includes drivers and restraints of the veterinary ultrasound scanners market and their impact on
Electronic Stethoscopes Market: Report Analysis Global Market Revenue and Share …
Electronics stethoscopes have emerged in the recent years. They are purely a development of technology that are meant to aid improved diagnosis of ailments, especially cardiovascular diseases. In the last few years, the global electronic stethoscopes market has registered phenomenal growth, and predictions are that it will record a better growth rate during the forecast period. As the future for global electronic stethoscopes market looks promising, Transparency Market Research is coming
Foley Catheters Market Growth Trends, In-depth Analysis, Business Strategies, an …
Global Foley Catheters Market: Overview This report analyzes the current and future scenario of the global Foley catheters market. Rise in prevalence of urologic diseases, such as urinary retention and prostate hypertrophy, across the globe and an increase in the geriatric population are major drivers of the global market. The global Foley catheters market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the

All 5 Releases


More Releases for Plasma

Bovine Blood Plasma Derivatives
Increasing use of bovine blood plasma derivatives in biopharmaceutical companies for cell culture technique, biotechnology, and research and development is expected to drive the market growth. For Instance, in November 2018, Wageningen University initiated the preclinical trial for Bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers including other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.
Platelet, Plasma Market
Platelet, Plasma Market is estimated to surpass $ 6.3 Billion markets in 2019 and reach USD 14.56 Billion by 2024, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period 2016-2024 globally. For More Information Visit https://www.maximizemarketresearch.com/market-report/platelet-plasma-market/11293/ A rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According
Global Blood Plasma Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia,
Cold Plasma Technology Market Size
This report focuses on the global Cold Plasma Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cold Plasma Technology development in United States, Europe and China. In 2017, the global Cold Plasma Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. Download FREE Sample of
Plasma Light Market: Pure Plasma Lighting, Lightahead, CozyCabin, RioRand, Cryst …
MarketResearchReports.Biz adds “Global Plasma Light Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Plasma Light market and the growth estimates for the forecasted period. This report studies the global Plasma Light market status and forecast, categorizes the global Plasma Light market size (value & volume) by key players, type, application, and region. This report focuses on the top
Plasma Equipment Market Trend to 2025 Profiling Plasma Air, Plasma etching techn …
The Plasma Equipment Market Research Report Forecast 2018-2025 is a valuable source of insightful data for business strategists. It provides the Plasma Equipment industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. In this report, the global Plasma Equipment market value is provided for 2017 in million-dollar terms